Delivery Order SPE2DB20D6037-SPE2DB25FTVY7
Award Date
6/25/25
Potential Completion Date
6/26/25
Potential Value
$7.2K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $12,730.46 firm fixed-price contract is for the supply of Otezla 30 mg tablets to support the medical needs of military healthcare facilities. The contract is not associated with a set-aside designation and is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, on September 27, 2024. The $8,422.01 order is for the pharmaceutical product Otezla 30 mg tablet, 60 count, and is part of the larger SPE2DB indefinite delivery contract (IDC) valued up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA. The SPE2DB IDC allows the DLA to issue firm fixed-price delivery...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $29,581.75, is for the delivery of OTEZLA 30 MG TABLET 60S to support the medical supply needs of military health facilities. DMS Pharmaceutical Group Inc. has a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, enabling the agency to issue...
This federal contract award is a $5,435.86 firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of Otezla 30 mg tablets, a specialized pharmaceutical product. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and...
The U.S. Defense Logistics Agency (DLA) awarded a $25,679.07 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The order is for the supply of 60-count bottles of Otezla 30 mg tablets, a pharmaceutical product used to treat certain medical conditions. This delivery order is issued under DMS Pharmaceutical Group's indefinite delivery contract SPE2DB24D2106 with DLA, which has a ceiling value of up to $4,999,999 and enables...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $29,849.49 firm fixed-price delivery order is for Otezla 30 mg tablets, a prescription medication, to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue...
This is a $6,702.80 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of OTEZLA 30 MG TABLET 60S, a pharmaceutical product, with a period of performance through December 18, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This is a firm fixed-price delivery order contract awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA) under the SPE2DB program. The contract has a ceiling value of $4,092.62 and covers the delivery of the pharmaceutical product "OTEZLA 30 MG TABLET 60S" with a period of performance through May 6, 2024. The DLA SPE2DB program is a single-award indefinite delivery contract (IDC) valued at up to...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide OTEZLA 30 mg tablets. The contract has a firm fixed price of $7,869.72 and a completion date of June 24, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen holds with the DLA to supply a wide range of pharmaceutical products and medical supplies to...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $59,937.03 contract is for the delivery of OTEZLA 30 MG TABLET 60S, a prescription medication. This order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, which provides a global pharmaceutical support vehicle through...